Literature DB >> 10955936

Ureteropelvic junction obstruction: morphological and clinical studies.

P L Zhang1, C A Peters, S Rosen.   

Abstract

This study included 27 patients with ureteropelvic (UPJ) obstruction. Both renal parenchyma and the junctional abnormality were examined and correlated with clinical findings. Renal biopsies were categorized into grades 1-4. Those with normal or minimal findings (grade 1 and 2, respectively) had excellent renal function as assessed by radionuclide studies. Those with grade 4 had severe histological abnormalities associated with poor renal function. Grade 3 renal changes were seen in patients whose renal function varied greatly and did not correlate with the extent of the limited histological abnormalities. Although there was great variation in the renal biopsies, glomerulosclerosis was a consistent finding, associated with extracapillary proliferation and periodic acid-Schiff-positive material (? Tamm-Horsfall protein) in the urinary space of glomeruli in 91% (10/11) of grade 3 or 4 renal biopsies. No extracapillary proliferation was seen in grade 1 renal biopsies. The UPJ obstruction area was consistently inflamed and markedly thickened due to varying degrees of perifascicular fibrosis and muscular hypertrophy. Extensive fibrosis with associated muscular atrophy was the most-severe change in this spectrum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955936     DOI: 10.1007/s004679900240

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  26 in total

1.  Ureteropelvic junction obstruction in children: 10 years' experience in one institution.

Authors:  Jin-Cherng Sheu; Chee-Chee Koh; Pei-Yei Chang; Nien-Lu Wang; Jeng-Daw Tsai; Tsuen-Chiuan Tsai
Journal:  Pediatr Surg Int       Date:  2006-05-16       Impact factor: 1.827

Review 2.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

3.  Mutation screening of BMP4 and Id2 genes in Chinese patients with congenital ureteropelvic junction obstruction.

Authors:  Jun Li He; Jun Hong Liu; Feng Liu; Ping Tan; Tao Lin; Xu Liang Li
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

Review 4.  Primary non-surgical management of unilateral ureteropelvic junction obstruction in children: a systematic review.

Authors:  Marcus Weitz; Maria Schmidt; Guido Laube
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

Review 5.  Anatomy and Physiology of the Urinary Tract: Relation to Host Defense and Microbial Infection.

Authors:  Duane R Hickling; Tung-Tien Sun; Xue-Ru Wu
Journal:  Microbiol Spectr       Date:  2015-08

6.  Pediatric ureteropelvic junction obstruction: can magnetic resonance urography identify crossing vessels?

Authors:  Kushal R Parikh; Matthew R Hammer; Kate H Kraft; Vesna Ivančić; Ethan A Smith; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2015-07-28

Review 7.  Chronic partial ureteral obstruction and the developing kidney.

Authors:  Robert L Chevalier
Journal:  Pediatr Radiol       Date:  2007-12-11

8.  Calcineurin is required in urinary tract mesenchyme for the development of the pyeloureteral peristaltic machinery.

Authors:  Ching-Pin Chang; Bradley W McDill; Joel R Neilson; Heidi E Joist; Jonathan A Epstein; Gerald R Crabtree; Feng Chen
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 9.  Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy.

Authors:  Robert L Chevalier; Barbara A Thornhill; Michael S Forbes; Susan C Kiley
Journal:  Pediatr Nephrol       Date:  2009-10-21       Impact factor: 3.714

10.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.